Literature DB >> 29173781

Psychopharmacology of Bipolar Disorders in Children and Adolescents.

Ekaterina Stepanova1, Robert L Findling2.   

Abstract

Bipolar disorder is a debilitating illness that often leads to functional impairment when untreated. Monotherapy with mood stabilizers is preferable, although combination therapy may be necessary in refractory cases. Most studies focus on the use of lithium, anticonvulsants, and second-generation antipsychotics in the treatment of acute manic or depressive phases, as well as maintaining adequate response after the episode. More research is needed in the area of psychopharmacology of pediatric bipolar disorder to bridge the gap between clinical needs and the available data.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescents; Bipolar disorder; Children; Pediatric; Pharmacotherapy

Mesh:

Substances:

Year:  2017        PMID: 29173781     DOI: 10.1016/j.pcl.2017.08.002

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  5 in total

Review 1.  The evidence-based choice for antipsychotics in children and adolescents should be guaranteed.

Authors:  Daria Putignano; Antonio Clavenna; Laura Reale; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2019-02-07       Impact factor: 2.953

2.  The stability of quetiapine oral suspension compounded from commercially available tablets.

Authors:  Jennie Tran; Melissa A Gervase; Jason Evans; Rebecca Deville; Xiaowei Dong
Journal:  PLoS One       Date:  2021-08-10       Impact factor: 3.240

3.  Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision.

Authors:  Young Sup Woo; Won-Myong Bahk; Jung Goo Lee; Jong-Hyun Jeong; Moon-Doo Kim; InKi Sohn; Se-Hoon Shim; Duk-In Jon; Jeong Seok Seo; Kyung Joon Min; Won Kim; Hoo-Rim Song; Bo-Hyun Yoon
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-11-30       Impact factor: 2.582

4.  A brief motivational intervention for enhancing medication adherence for adolescents with bipolar disorder: A pilot randomized trial.

Authors:  Tina R Goldstein; Megan L Krantz; Rachael K Fersch-Podrat; Nina J Hotkowski; John Merranko; Loren Sobel; David Axelson; Boris Birmaher; Antoine Douaihy
Journal:  J Affect Disord       Date:  2020-01-07       Impact factor: 4.839

5.  Characteristics Associated with Depression Severity in 270 Juveniles in a Major Depressive Episode.

Authors:  Giulia Serra; Maria Elena Iannoni; Monia Trasolini; Gino Maglio; Camilla Frattini; Maria Pia Casini; Ross J Baldessarini; Stefano Vicari
Journal:  Brain Sci       Date:  2021-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.